☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to filed such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~November 12, 2020,~~May 14, 2021, there were ~~35,009,952~~53,311,898 shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding.

	September 30, 2020			December 31, 2019			March 31, 2021			December 31, 2020
	(Unaudited)						(Unaudited)
Assets
Current Assets
Cash	$	2,092,532		$	1,587,250		$	8,515,824		$	4,387,416
Restricted cash		150,130			150,130			150,130			150,130
Accounts receivable, net		57,917			38,526			67,674			133,719
Inventory, net		872,336			1,303,279			780,479			767,351
Prepaid expenses and other current assets		385,170			285,495			536,268			455,553
Total Current Assets		3,558,085			3,364,680			10,050,375			5,894,169
Property and equipment:
Equipment		183,044			183,044			183,044			183,044
Furniture and fixtures		98,839			98,839			98,839			98,839
Tooling and molds		644,462			644,462			644,462			644,462
		926,345			926,345			926,345			926,345
Accumulated depreciation		(880,821	)		(831,290	)		(913,149	)		(897,137	)
Property and equipment, net		45,524			95,055			13,196			29,208
Right-of-use assets		320,378			108,508			292,797			306,786
Goodwill		15,479,662			15,479,662			15,479,662			15,479,662
Other intangible assets, net of amortization of $3,174,086 and $2,604,290, respectively		5,430,481			6,000,277
Other intangible assets, net of amortization of $3,553,950 and $3,366,105, respectively								5,050,617			5,238,462
Total Assets	$	24,834,130		$	25,048,182		$	30,886,647		$	26,948,287

Liabilities, Series C Preferred Stock and Stockholders’ Equity
Current Liabilities
Accounts payable	$	1,997,105		$	2,118,476		$	2,305,317		$	2,748,814
Accrued expenses		1,289,433			1,492,111			1,717,711			1,315,262
Short-term debt								45,000			346,390
Term loan facility - current		2,062,500			2,062,500			2,062,500			2,062,500
Other short-term debt		346,390			-
Total Current Liabilities		5,695,428			5,673,087			6,130,528			6,472,966

Term loan facility, net of debt discount of $163,702 and $244,070, respectively, and deferred debt issuance costs of $846,828 and $1,262,565, respectively		8,538,472			9,739,242
Term loan facility, net of debt discount of $60,055 and $137,855, respectively, and deferred debt issuance costs of $310,665 and $713,119, respectively								3,147,032			8,182,403
Other long-term liabilities		1,341,078			1,113,965			1,311,209			1,326,409
Total Liabilities		15,574,978			16,526,294			10,588,769			15,981,778

Commitments and Contingencies
Series C Preferred Stock
Series C Preferred Stock, par value $0.0001 per share: 2,000 shares designated; 2,000 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively		1,807,300			1,807,300
Series C Preferred Stock, par value $0.0001 per share: 2,000 shares designated; 2,000 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively								1,807,300			1,807,300
Stockholders’ Equity
Preferred Stock, par value $0.0001 per share: 10,000,000 shares authorized
Series A Preferred Stock, par value $0.0001 per share: 3,125,000 shares designated; 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively		-			-
Series B Preferred Stock, par value $0.0001 per share: 4,500,000 shares designated; 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively		-			-
Common Stock, par value $0.0001 per share: 100,000,000 shares authorized; 35,009,952 and 30,048,854 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively		3,501			3,005
Series A Preferred Stock, par value $0.0001 per share: 3,125,000 shares designated; 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively								-			-
Series B Preferred Stock, par value $0.0001 per share: 4,500,000 shares designated; 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively								-			-
Series D Preferred Stock, par value $0.0001 per share: 1,515,151 shares designated; 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively								-			-
Series E Preferred Stock, par value $0.0001 per share: 1,476,016 shares designated; 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively								-			-
Common Stock, par value $0.0001 per share: 100,000,000 shares authorized; 53,311,898 and 40,619,974 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively								5,331			4,062
Additional paid-in capital		70,560,348			68,515,674			89,616,202			74,583,144
Accumulated deficit		(63,111,997	)		(61,804,091	)		(71,130,955	)		(65,427,997	)
Total Stockholders’ Equity		7,451,852			6,714,588			18,490,578			9,159,209
Total Liabilities, Series C Preferred Stock and Stockholders’ Equity	$	24,834,130		$	25,048,182		$	30,886,647		$	26,948,287

The accompanying notes are an integral part of these condensed consolidated financial statements.

							For the Three Months Ended
	For the Nine Months Ended						March 31,
	September 30,						2021			2020
	2020			2019
Revenues	$	8,866,205		$	13,112,952		$	2,438,682		$	3,744,029
Cost of goods sold		2,378,148			3,206,340			888,093			948,124

Gross Profit		6,488,057			9,906,612			1,550,589			2,795,905

Operating Expenses
General and administrative		3,455,555			4,642,836			1,498,123			844,206
Selling and marketing		1,865,626			2,503,594			560,441			725,681
Research and development		757,221			962,537			274,915			186,612

Total Operating Expenses		6,078,402			8,108,967			2,333,479			1,756,499

Operating Income		409,655			1,797,645
Operating (Loss) Income								(782,890	)		1,039,406

Other Income and (Expense)
Interest expense		(1,717,561	)		(2,410,741	)		(861,248	)		(601,342	)
Loss on extinguishment of debt		-			(2,343,879	)
Change in fair value of contingent consideration		-			85,111
Warrant modification expense								(2,881,729	)		-
Forgiveness of PPP loan and accrued interest								303,710			-
Total Other Expense, Net		(1,717,561	)		(4,669,509	)		(3,439,267	)		(601,342	)

Loss from Continuing Operations		(1,307,906	)		(2,871,864	)
Loss from Discontinued Operations		-			(3,432,270	)
Loss on sale of Discontinued Operations		-			(5,988,767	)
Net Loss		(1,307,906	)		(12,292,901	)
Preferred stock dividends		(75,000	)		(125,000	)
(Loss) Income before Income Taxes								(4,222,157	)		438,064
Provision for Income Taxes								-			-

Net Loss applicable to Common Stockholders	$	(1,382,906	)	$	(12,417,901	)
Net (Loss) Income								(4,222,157	)		438,064
Preferred stock dividends, including deemed dividend on redeemable Series E convertible preferred stock								(1,555,801	)		(25,000	)

Loss Per Share from Continuing Operations – Basic and Diluted	$	(0.04	)	$	(0.11	)
Loss Per Share from Discontinued Operations – Basic and diluted	$	0.00		$	(0.33	)
Net (Loss) Income applicable to Common Stockholders							$	(5,777,958	)	$	413,064

Net Loss Per Share – Basic and Diluted	$	(0.04	)	$	(0.44	)
Net (Loss) Income Per Share – Basic and Diluted							$	(0.12	)	$	0.01

Weighted Average Number of Common Shares Outstanding – Basic and Diluted		31,580,897			28,328,095			48,192,546			30,153,203

The accompanying notes are an integral part of these condensed consolidated financial statements.

~~The accompanying notes are an integral part of these condensed consolidated financial statements.~~

The accompanying notes are an integral part of these condensed consolidated financial statements.

~~The accompanying notes are an integral part of these condensed consolidated financial statements.~~

							For the Three Months Ended
	For the Nine Months Ended						March 31,
	September 30,						2021			2020
	2020			2019
Cash Flows from Operating Activities
Net Loss	$	(1,307,906	)	$	(12,292,901	)
Loss from discontinued operations		-			(3,432,270	)
Loss on sale of discontinued operations		-			(5,988,767	)
Loss from continuing operations		(1,307,906	)		(2,871,864	)
Adjustments to reconcile net loss to net cash provided by operating activities of continuing operations:
Net (Loss) Income							$	(4,222,157	)	$	438,064
Adjustments to reconcile net (loss) income to net cash used in operating activities of continuing operations:
Depreciation		49,531			55,843			16,012			16,898
Stock based compensation		120,000			520,191			40,000			40,000
Amortization of debt discount		80,368			191,212			77,800			28,672
Amortization of intangible assets		569,796			569,796			187,845			187,845
Amortization of deferred debt issuance costs		415,737			521,118			402,454			148,317
Change in fair value of contingent consideration		-			(85,111	)
Loss on extinguishment of debt		-			2,343,879
Non-cash charge for modification of warrant terms								2,881,729			-
Forgiveness of PPP loan and accrued interest								(303,710	)		-
Changes in operating assets and liabilities:
Accounts receivable		(19,391	)		202,614			66,045			2,563
Inventory		430,943			(633,764	)		(13,128	)		353,496
Prepaid expenses and other current assets		(99,675	)		20,213			(80,715	)		(96,792	)
Accounts payable		(162,119	)		795,176			(518,601	)		(402,711	)
Accrued expenses		(61,641	)		(149,180	)		463,660			(199,092	)
Total Adjustments		1,323,549			4,351,987			3,219,391			79,196
Net Cash Provided by Operating Activities of Continuing Operations		15,643			1,480,123
Net Cash (Used in) Provided by Operating Activities								(1,002,766	)		517,260

Cash flows from Investing Activities
Pay down of contingent consideration		-			(181,065	)
Net proceeds received from sale of discontinued operations		-			2,955,170
Purchase of equipment		-			(23,791	)
Net Cash Provided by Investing Activities of Continuing Operations		-			2,750,314
Net Cash Used in Investing Activities								-			-

Cash Flows from Financing Activities
Pay down of short-term debt		-			(638,881	)
Proceeds received in connection with issuance of common stock, net		1,864,528			3,214,042
Repayment of term debt with Sagard Capital		-			(16,000,000	)
Term loan borrowings, net of deferred debt issue costs		-			14,670,579
Term loan repayment		(1,696,875	)		(2,675,998	)		(5,515,625	)		(665,625	)
Proceeds received in connection with issuance of Series E preferred stock, net								4,000,003			-
Proceeds from exercise of common stock warrants								6,670,494			-
Payment of closing related fees		(24,404	)		(47,671	)		(23,698	)		-
Proceeds from PPP loan		346,390			-
Net Cash Provided by (Used in) Financing Activities of Continuing Operations		489,639			(1,477,929	)
Net Increase in Cash and Restricted Cash from Continuing Operations		505,282			2,752,508

Cash Flows from Discontinued Operations:
Cash used by operating activities of discontinued operations		-			(2,844,419	)
Cash used in investing activities of discontinued operations		-			(21,849	)
Net Cash Used by Discontinued Operations		-			(2,866,268	)
Net Cash Provided by (Used in) Financing Activities								5,131,174			(665,625	)
Net Increase (Decrease) in Cash and Restricted Cash		505,282			(113,760	)		4,128,408			(148,365	)
Cash and Restricted Cash – Beginning of Period		1,737,380			1,614,641			4,537,546			1,737,380
Cash and Restricted Cash – End of Period	$	2,242,662		$	1,500,881		$	8,665,954		$	1,589,015

Supplemental Disclosures of Cash Flow Information:
Cash paid during the periods for:
Interest	$	1,241,819		$	1,564.376		$	443,975		$	431,804
Taxes	$	10,014		$	11,359		$	25,999		$	16,351
Non-cash financing activities:
Accrued fees incurred in connection with equity offerings	$	40,748		$	78,843		$	20,458		$	-
Common Stock issued in connection with management incentive plans	$	200,794		$	216,267		$	80,456		$	116,628
Issuance of common stock in connection with conversion of Series E preferred stock							$	4,000,003		$	-
Accrued Series C Preferred Stock dividends	$	25,000		$	25,000		$	75,000		$	25,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

Nxt-ID, Inc. (“Nxt-ID” or the “Company”) was incorporated in the State of Delaware on February 8, 2012. The Company ~~is a security~~provides technology ~~company and operates its business in one segment – hardware and software security systems and applications. The Company is engaged in the development of proprietary~~ products and ~~solutions that serve multiple end markets, including the security,~~services for healthcare ~~financial technology and the Internet of Things (“IoT”) markets.~~applications. The Company evaluates the performance of its business on, among other things, profit and loss from operations. ~~With~~The Company has extensive experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization, ~~and~~ sensor technologies, ~~the Company develops and markets solutions for payment, IoT~~ and healthcare applications.

The Company’s wholly-owned subsidiary, LogicMark LLC (“LogicMark”), manufactures and distributes non-monitored and monitored personal emergency response systems sold through the United States Department of Veterans Affairs, ~~(the “VA”),~~ healthcare durable medical equipment dealers and distributors and monitored security dealers and distributors.

The Company’s former wholly-owned subsidiary, Fit Pay, Inc., had a proprietary technology platform that delivers payment, credential management, authentication and other secure services to the IoT ecosystem. The platform uses tokenization, a payment security technology that replaces cardholders’ account information with a unique digital identifier, to transact highly secure contactless payment and authentication services. On September 21, 2018, the Company announced that its board of directors approved a plan to separate the Company’s financial technology business from our healthcare business into an independent publicly traded company. The Company originally planned to distribute shares of PartX, Inc., a newly created company and wholly-owned subsidiary of the Company (“PartX”), to our stockholders through the execution of a spin-off. As a result, the Company reclassified its financial technology business to discontinued operations for all periods reported. The Company’s financial technology business was comprised of its Fit Pay subsidiary and the intellectual property developed by the Company, including the Flye Smartcard and the Wocket. On April 29, 2019, a Registration Statement on Form 10 was filed by PartX with the U.S. Securities and Exchange Commission (the “SEC”) in connection with the planned spin-off of our payments, authentication and credential management business. On August 19, 2019, the Company’s subsidiary, PartX notified the SEC that it was withdrawing the Registration Statement on Form 10. With the approval of the Company’s board of directors, and upon similar terms and conditions to those set forth in that loan agreement, the Company entered into a non-binding letter of intent for the sale of its Fit Pay subsidiary, excluding certain assets on August 6, 2019. In connection with the letter of intent, the Company was advanced $500,000 of non-interest bearing working capital for Fit Pay. On September 9, 2019, the Company completed the sale of its Fit Pay subsidiary to Garmin International, Inc. for $3.32 million in cash.

The accompanying unaudited condensed consolidated financial statements as of ~~September 30, 2020,~~March 31, 2021, and for the ~~nine and~~ three months ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~ have been prepared in accordance with the accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC and on the same basis as the Company prepares its annual audited consolidated financial statements. The unaudited condensed consolidated balance sheet as of ~~September 30, 2020~~March 31, 2021 and the condensed consolidated statements of operations, ~~and~~ changes in equity ~~for the nine~~ and ~~three months ended September 30, 2020 and September 30, 2019 and the condensed consolidated statements of~~ cash flows for the ~~nine~~three months ended ~~September 30,~~March 31, 2021 and March 31, 2020 ~~and September 30, 2019~~ are unaudited, but include all adjustments, consisting only of normal recurring adjustments, which the Company considers necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The results for the ~~nine and~~ three months ended ~~September 30, 2020~~March 31, 2021 are not necessarily indicative of results to be expected for the year ending December 31, ~~2020,~~2021, or for any future interim period. The condensed consolidated balance sheet at December 31, ~~2019~~2020 has been derived from audited consolidated financial statements. However, it does not include all of the information and notes required by U.S. GAAP for complete consolidated financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, ~~2019~~2020 and the notes thereto included in the Company’s Annual Report on Form 10-K, which was filed with the SEC on ~~March 30, 2020.~~April 15, 2021.

The Company generated an operating ~~income~~loss of ~~$409,655~~$782,890 and a net loss of ~~$1,307,906~~$4,222,157 during the ~~nine~~three months ended ~~September 30, 2020.~~March 31, 2021. As of ~~September 30, 2020,~~March 31, 2021, the Company had cash and stockholders’ equity of ~~$2,092,532~~$8,515,824 and ~~$7,451,852,~~$18,490,578, respectively. At ~~September 30, 2020,~~March 31, 2021, the Company had a working capital ~~deficiency~~ of ~~$2,137,343. On July 14, 2020, the Company, received gross proceeds of $1,864,528 from a registered direct offering. See Note 6 for details of this transaction.~~$3,919,847.

Given the Company’s cash position at ~~September 30, 2020~~March 31, 2021 and its projected cash flow from operations, the Company believes that it will have sufficient capital to sustain operations for a period of one year following the date of this filing. The Company may also raise ~~additional~~ funds through equity or debt offerings to increase its working capital and to accelerate the execution of its long-term strategic plan to develop and commercialize its core products and to fulfill its product development commitments.

As described in Note 7,6, the coronavirus ~~has significantly impacted, and~~ could continue to significantly impact the Company’s business, which would require the Company to raise funds to assist with its working capital needs.

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the ~~condensed~~ consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions including those related to the fair value of acquired assets and liabilities, stock based compensation, derivative instruments, income taxes, accounts receivable and inventories, right-of-use assets and other matters that affect the condensed consolidated financial statements and disclosures. Actual results could differ from those estimates.

The condensed consolidated financial statements include the accounts of Nxt-ID and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.

The Company’s revenues consist of product sales to either end customers or to distributors and its sales are recognized at a point-in-time under the core principle of recognizing revenue when control of the product transfers to the customer. The Company recognizes revenue when it ships or delivers the product from its fulfillment center to its customer, when the customer accepts and has legal title of the product, and the Company has a present right to payment for the product. For the ~~nine~~three months ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the Company had no sales recognized over time. The Company invoices its customers at the same time that the Company’s performance obligation is satisfied. The Company generally receives customer orders with a specified delivery date and orders typically fluctuate from month-to-month based on customer demand and general business conditions.

The Company offers standard product warranty coverage which provides assurance that the Company’s products will conform to the contractually agreed-upon specifications for a limited period from the date of shipment. The Company’s warranty liabilities and related expense have not been material and were not material in the accompanying condensed consolidated financial statements as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, and for the ~~nine~~three months ended ~~September 30, 2020~~March 31, 2021 and ~~2019.~~2020.

Accounts receivable is stated at net realizable value. The Company regularly reviews accounts receivable balances and adjusts the receivable reserves as necessary whenever events or circumstances indicate the carrying value may not be recoverable. At ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company had an allowance for doubtful accounts of ~~$126,733.~~$52,111 and $126,733, respectively.

The Company performs regular reviews of inventory quantities on hand and evaluates the realizable value of its inventories. The Company adjusts the carrying value of the inventory as necessary with estimated valuation reserves for excess, obsolete, and slow-moving inventory by comparing the individual inventory parts to forecasted product demand or production requirements. As of ~~September 30, 2020,~~March 31, 2021, inventory was comprised of ~~$202,526~~$204,695 in raw materials and ~~$669,810~~$575,784 in finished goods on hand. Inventory at December 31, ~~2019~~2020 was comprised of ~~$167,357~~$199,523 in raw materials and ~~$1,135,922~~$567,828 in finished goods on hand. The Company is required to prepay for certain inventory with certain vendors until credit terms can be established. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company had prepaid inventory of ~~$216,587~~$353,173 and ~~$201,496,~~$332,475, respectively. These prepayments were made primarily for finished goods inventory, and prepaid inventory is included in prepaid expenses and other current assets on the condensed consolidated balance sheets.

Authoritative accounting guidance allows the Company to first assess qualitative factors to determine whether it is necessary to perform the more detailed two-step quantitative goodwill impairment test. The Company performs the quantitative test if its qualitative assessment determined it is more likely than not that a reporting unit’s fair value is less than its carrying amount. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test for any reporting units or assets. The quantitative goodwill impairment test, if necessary, is a two-step process. The first step is to identify the existence of a potential impairment by comparing the fair value of a reporting unit (the estimated fair value of a reporting unit is calculated using a discounted cash flow model) with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, the reporting unit’s goodwill is considered not to be impaired and performance of the second step of the quantitative goodwill impairment test is unnecessary. However, if the carrying amount of a reporting unit exceeds its fair value, the second step of the quantitative goodwill impairment test is performed to measure the amount of impairment loss to be recorded, if any. The second step of the quantitative goodwill impairment test compares the implied fair value of the reporting unit’s goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit’s goodwill exceeds its implied fair value, an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined using the same approach as employed when determining the amount of goodwill that would be recognized in a business combination. That is, the fair value of the reporting unit is allocated to all of its assets and liabilities as if the reporting unit had been acquired in a business combination and the fair value was the purchase price paid to acquire the reporting unit.

As part of the annual evaluation of the LogicMark related goodwill, the Company utilized the option to first assess qualitative factors, which include but are not limited to, economic, market and industry conditions, as well as the financial performance of LogicMark. In accordance with applicable guidance, an entity is not required to calculate the fair value of a reporting unit if, after assessing these qualitative factors, the Company determines that it is more likely than not that its reporting unit’s fair value is greater than its carrying amount. As of September 30, 2020, the Company determined that it was more likely than not that the fair value of LogicMark exceeded its respective carrying amount and therefore, a quantitative assessment was not required.

At ~~September 30,~~March 31, 2021, the other intangible assets relating to the acquisition of LogicMark are comprised of patents of $2,353,804; trademarks of $962,990; and customer relationships of $1,733,823. At December 31, 2020, the other intangible assets relating to the acquisition of LogicMark are comprised of patents of ~~$2,539,656;~~$2,445,709; trademarks of ~~$994,342;~~$978,494; and customer relationships of $1,896,483. At December 31, 2019, the other intangible assets relating to the acquisition of LogicMark are comprised of patents of $2,818,434; trademarks of $1,041,370; and customer relationships of $2,140,473.$1,814,259. The Company will continue amortizing these intangible assets using the straight-line method over their estimated useful lives which for the patents, trademarks and customer relationships are 11 years; 20 years; and 10 years, respectively. During the ~~nine and~~ three months ended ~~September 30,~~March 31, 2021 and 2020, the Company had amortization expense of ~~$569,796~~$187,845 and ~~$192,019, respectively, related to the LogicMark intangible assets. During the nine and three months ended September 30, 2019, the Company had amortization expense of $569,796 and $192,019,~~$187,845, respectively, related to the LogicMark intangible assets.

As of ~~September 30, 2020,~~March 31, 2021, total amortization expense estimated for the remainder of fiscal year ~~2020~~2021 is approximately ~~$192,000,~~$574,000, and for each of the next five fiscal years, ~~2021~~2022 through ~~2025,~~2026, the total amortization expense is estimated to be as follows: ~~2021 - $762,000;~~ 2022 - $762,000; 2023 - $762,000; 2024 - $762,000; ~~and~~ 2025 - ~~$762,000.~~$762,000; and 2026 - $619,000.

The Company accounts for share-based awards exchanged for employee services at the estimated grant date fair value of the award. The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Non-employee stock-based compensation charges are amortized over the vesting period or as earned. Stock-based compensation is recorded in the same component of operating expenses as if it were paid in cash. The Company generally issues new shares of common stock to satisfy conversion and warrant exercises.

Basic loss per share was computed using the weighted average number of shares of common stock outstanding. Diluted loss per share includes the effect of diluted common stock equivalents. Potentially dilutive securities from the exercise of stock options to purchase ~~310,272~~363,640 shares of common stock and warrants to purchase ~~12,302,939~~9,378,133 shares of common stock as of ~~September 30, 2020~~March 31, 2021 were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. As of ~~September 30, 2019,~~March 31, 2020, potentially dilutive securities from the exercise of stock options to purchase 114,288 shares of common stock and warrants to purchase 6,973,221 shares of common stock were excluded from the computation of diluted net loss per share because the ~~effect~~exercise price of ~~their inclusion would have been anti-dilutive.~~the common stock equivalents was greater than the average market price of the common shares for the three month period ended March 31, 2020.

In August 2018, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) ASU 2018-13, which eliminates, adds and modifies certain disclosure requirements for fair value measurements as part of the FASB’s disclosure framework project. Adoption of this guidance is required for fiscal years and interim periods within those fiscal years, beginning after December 15, 2019. This ASU was adopted and did not have a material impact on the Company’s condensed consolidated financial statements.

~~Other recent~~Recent accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

~~The following table represents the financial results of the discontinued operations for the nine and three months ended September 30, 2019:~~

On May 24, 2018, LogicMark, a wholly-owned subsidiary of Nxt-ID, entered into a Senior Secured Credit Agreement (the “Credit Agreement”) with the lenders thereto and Sagard Holdings Manager LP, as administrative agent and collateral agent for the lenders party to the Credit Agreement (collectively, the “Lender”), whereby the Lender extended a term loan (the “Term Loan”) to LogicMark in the principal amount of $16,000,000. The original maturity date of the Term Loan was May 24, 2023. The Term Loan Facility with Sagard Holdings Manager LP was repaid on May 3, 2019 with Term Loan proceeds received from CrowdOut Capital LLC (See below). The outstanding principal amount of the Term Loan base interest at a rate of LIBOR, adjusted monthly, plus 9.5% per annum (approximately 11.99% as of April 30, 2019). The Company incurred $1,253,970 in deferred debt issue costs related to the Term Loan. During the nine and three months ended September 30, 2019, the Company amortized $86,969 and $0, respectively, of the deferred debt issue costs which is included in interest expense in the condensed consolidated statement of operations.

On May 24, 2018, the Company recorded a debt discount of $705,541. The debt discount is attributable to the aggregate fair value on the issuance date of both Sagard Warrants. The debt discount was amortized using the effective interest method over the five-year term of the Term Loan. During the nine and three months ended September 30, 2019, the Company recorded $48,932 and $0, respectively of debt discount amortization related to the Sagard Warrants. The debt discount amortization is included as part of interest expense in the condensed consolidated statement of operations.

On May 3, 2019, LogicMark completed the closing of a $16,500,000 senior secured term loan with the lenders thereto and CrowdOut Capital LLC, as administrative agent. The Company used the proceeds from the term loan to repay LogicMark’s ~~existing~~prior term loan facility with Sagard Holdings Manager LP and to pay other costs related to the refinancing. The original maturity date of the term loan iswith CrowdOut Capital LLC was May 3, 2022 and ~~requires~~required the Company to make minimum principal payments over the three-year term amortized over 96 months. During the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, the Company ~~has~~ made scheduled principal repayments totaling ~~$1,546,875. In addition,~~$515,625. On February 8, 2021, LogicMark entered into a second amendment to the ~~Company prepaid an additional $150,000~~senior secured term loan with CrowOut Capital LLC. Pursuant to the second amendment, LogicMark made a $5,000,000 voluntary prepayment on the principal amount of the term loan ~~with CrowdOut Capital LLC during~~and paid a prepayment premium of $125,000, which was equivalent to 2.5% of the ~~nine~~prepayment, rather than 5% of the prepayment as required by the Credit Agreement. The prepayment premium is included in interest expense for three months ended ~~September 30, 2020 with cash flow generated from~~March 31, 2021 in the condensed consolidated statement of operations. In addition, the maturity date of the term loan was extended to March 22, 2023. The outstanding principal amount of the ~~term loan~~Term Loan bears interest at a rate of LIBOR, adjusted monthly, plus 11.0% per annum (approximately 13.0% as of ~~September 30, 2020)~~March 31, 2021). The Company incurred $412,500 in original issue discount for closing related fees charged by the Lender. During the ~~nine and~~ three months ended ~~September 30, 2020,~~March 31, 2021, the Company amortized ~~$80,368 and $25,849, respectively~~$77,800 of the original issue discount which is included in interest expense in the condensed consolidated statement of operations. At ~~September 30, 2020~~March 31, 2021 the unamortized balance of the original issue discount was ~~$163,702.~~$60,055. The Company also incurred $1,831,989 in deferred debt issue costs related to the term loan. The deferred debt issue costs include an exit fee of $1,072,500 which is equivalent to 6.5% of the term loan amount borrowed from CrowdOut Capital. The exit fee is due to CrowdOut Capital upon the earlier of final repayment of the term loan facility or the maturity date. The liability for the exit fee is included as part of other long-term liabilities in the Company’s condensed consolidated balance sheet. During the ~~nine and~~ three months ended ~~September 30, 2020,~~March 31, 2021, the Company amortized ~~$415,737 and $133,710, respectively~~$402,454 of the deferred debt issue costs which is included in interest expense in the condensed consolidated ~~statement~~statements of operations. At ~~September 30, 2020~~March 31, 2021 the unamortized balance of deferred debt ~~issuance~~issue costs ~~were $846,828.~~was $310,665.

2020 (remainder)	$	515,625
2021		2,062,500
2021 (remainder)			$	1,546,875
2022		9,033,377		2,062,500
2023				1,970,877
Total term debt	$	11,611,502	$	5,580,252

~~The senior secured term loan contains customary financial covenants. As of September 30,~~On November 16, 2020, the Company ~~was in compliance with such covenants; see Subsequent Events (Note 8) regarding~~and CrowdOut Capital LLC, as administrative agent, entered into the first amendment to the senior secured term loan. In connection with the first amendment, CrowdOut Capital LLC, as administrative agent, agreed to modify the financial ratios contained in the senior secured term retroactively and prospectively. Based on the senior secured term loan, as amended, the Company was in compliance with such covenants at March 31, 2021.

On each of May 6 and May 8, 2020, Nxt-ID Inc. and LogicMark, LLC, a wholly owned subsidiary of the Company (the “Borrowers”), respectively, received loans (the “Loans”) from Bank of America, NA in the aggregate amount of $346,390, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act, which was enacted on March 27, 2020.

The Loans, which are in the form of PPP promissory notes and agreements, dated May 1, 2020 (the “Note Agreements”), mature on May 6 and May 8, 2022, respectively, and bear interest at a rate of 1.00% fixed per annum, payable monthly commencing on November 6 and November 8, 2020, respectively. The Loans may be prepaid by the Borrowers at any time prior to maturity with no prepayment penalties. The Borrowers used the proceeds from the Loans for payroll, payroll taxes, and group healthcare benefits. Under the terms of the Note Agreements, certain amounts of the Loans may be forgiven if they are used for qualifying expenses, as described in the Note Agreements.

On March 2, 2021, the Company’s wholly-owned subsidiary, LogicMark, LLC received notification from the Small Business Administration that repayment of its loan under the Paycheck Protection Program in the amount of $301,390 plus accrued interest of $2,320 has been forgiven. The ~~Company intends to apply for~~income resulting from the forgiveness of the ~~Loans~~PPP loan and ~~as such has treated the Loans as~~accrued interest is included in other ~~short-term debt on~~income in the Company’s condensed consolidated ~~balance sheet.~~statement of operations for the three months ended March 31, 2021. The Company has also applied for forgiveness of its PPP loan in the amount of $45,000; however, as of the date of this filing, the Company has not received formal notification from the SBA that such loan repayment has been forgiven.

On February 2, 2021, the Company closed a registered direct offering pursuant to which the Company issued (i) an aggregate of 1,476,016 shares of Series E preferred stock, convertible into an aggregate of up to 2,952,032 shares of common stock, (ii) common stock purchase warrants to purchase up to an aggregate of 1,000,000 shares of common stock at an exercise price of $1.23 per share, subject to customary adjustments thereunder, which were exercisable immediately upon issuance and have a term of five years, and (iii) common stock purchase warrants to purchase up to an aggregate of 1,952,032 shares of common stock at an exercise price of $1.23 per share with a term of five and one-half (5.5) years first exercisable six (6) months after issuance, subject to customary adjustments thereunder, for gross proceeds of $4,000,003, before deducting any offering expenses. The Company will use the net proceeds from this offering for working capital and liability reduction purposes including additional term debt repayment. In February 2021, 1,476,016 shares of Series E preferred stock were converted into 2,952,032 shares of common stock. During the three months ended March 31, 2021, the Company recorded a deemed dividend of $1,480,801 from the beneficial conversion feature associated with the issuance of the Series E convertible preferred stock and warrants.

On December 18, 2020, the Company closed a registered direct offering pursuant to which the Company issued (i) an aggregate of 1,515,151 shares of Series D preferred stock, convertible into an aggregate of up to 3,030,304 shares of common stock, (ii) common stock purchase warrants to purchase up to an aggregate of 1,000,000 shares of common stock at an exercise price of $0.49 per share, subject to customary adjustments thereunder, which were exercisable immediately upon issuance and have a term of five years, and (iii) common stock purchase warrants to purchase up to an aggregate of 5,060,606 shares of common stock at an exercise price of $0.49 per share with a term of five and one-half (5.5) years first exercisable six (6) months after issuance, subject to customary adjustments thereunder, for gross proceeds of $2,000,000, before deducting any offering expenses. The Company will use the net proceeds from this offering for working capital, new product initiatives and other general corporate purposes. On December 21, 2020, 1,515,151 shares of Series D preferred stock were converted into 3,030,304 shares of common stock. During the year ended December 31, 2020, the Company recorded a deemed dividend of $758,922 from the beneficial conversion feature associated with the issuance of the Series D convertible preferred stock and warrants.

On July 14, 2020, the Company closed a registered direct offering of (i) an aggregate of 3,778,513 shares of the Company’s common stock, par value $0.0001 per share; (ii) pre-funded warrants to purchase up to an aggregate of 734,965 shares of Common Stock at an exercise price of $0.01 per share, subject to customary adjustments thereunder; (iii) registered warrants, with a term of five (5) years exercisable immediately upon issuance, to purchase an aggregate of up to 1,579,718 shares of Common Stock (at an exercise price of $0.50 per share, subject to customary adjustments thereunder; and (iv) unregistered warrants, with a term of five and one-half (5.5) years first exercisable six (6) months after issuance, to purchase an aggregate of up to 3,750,000 shares of Common Stock at an exercise price of $0.65 per share, subject to customary adjustments thereunder, for gross proceeds of $1,864,528, before deducting any offering expenses. The Company will continue to use the net proceeds from this Offering for working capital, new product initiatives and other general corporate purposes.

On July 28, 2020, the Company received proceeds of $7,350 in connection with the exercise of 734,965 pre-funded warrants to purchase common stock at an exercise price of $0.01.

On January 8, 2019, the Company entered into a sales agreement with A.G.P./Alliance Global Partners (“A.G.P.”) for an at-the-market offering, pursuant to which the Company could sell, at its option, shares of its common stock, par value $0.0001 per share, having an aggregate offering price of up to $15 million to or through A.G.P., as sales agent. The Company was obligated to pay A.G.P. commissions for its services in acting as the Company’s sales agent in the sale of its common stock pursuant to the sales agreement. A.G.P. was entitled to compensation at a fixed commission rate of 3.0% of the gross proceeds from the sale of the Company’s common stock on the Company’s behalf pursuant to the sales agreement. The Company also agreed to reimburse A.G.P. for its reasonable out-of-pocket expenses, including the fees and disbursements of counsel to A.G.P., incurred in connection with the offering, in an amount not to exceed $35,000. During the three months ended March 31, 2019, the Company received $1,282,810 in net proceeds from the sale of 1,084,227 shares of its common stock under the sales agreement with A.G.P. The sales agreement with A.G.P. was terminated on October 10, 2019.

On January 4, 2013, a majority of the Company’s stockholders approved by written consent the Company’s 2013 Long-Term Stock Incentive Plan (“LTIP”). The maximum aggregate number of shares of common stock that may be issued under the LTIP, including stock awards, stock issued to directors for serving on the Company’s board of directors, and stock appreciation rights, is limited to 10% of the shares of common stock outstanding on the first business or trading day of any fiscal year, which is ~~592,223~~1,201,715 shares of common stock at January 1, ~~2020.~~2021.

~~During the nine months ended September 30, 2020,~~On March 31, 2021, the Company issued an aggregate of ~~310,272~~28,368 stock options to purchase shares of common stock under the LTIP to four (4) non-employee directors for serving on the Company’s board. The ~~weighted average~~ exercise price of these stock options is ~~approximately $0.39~~$1.41 and stock options were fully vested at the issuance date. The aggregate fair value of the stock options issued to the directors was ~~$120,000.~~$40,000.

On August 24, 2017, a majority of the Company’s stockholders approved at the 2017 Annual Stockholders’ Meeting the 2017 Stock Incentive Plan (“2017 SIP”). The aggregate maximum number of shares of common stock (including shares underlying options) that may be issued under the 2017 SIP pursuant to awards of restricted shares or options will be limited to 10% of the outstanding shares of common stock, which calculation shall be made on the first (1^st) business day of each new fiscal year; provided that for fiscal year 2017, 1,500,000 shares of common stock may be delivered to participants under the 2017 SIP. Thereafter, the 10% provision shall govern the 2017 SIP. The number of shares of common stock that are the subject of awards under the 2017 SIP which are forfeited or terminated, are settled in cash in lieu of shares of common stock or are settled in a manner such that all or some of such shares covered by an award are not issued to a participant or are exchanged for awards that do not involve shares of common stock will again immediately become available to be issued pursuant to awards granted under the 2017 SIP. If shares of common stock are withheld from payment of an award to satisfy tax obligations with respect to the award, those shares of common stock will be treated as shares that have been issued under the 2017 SIP and will not again be available for issuance under the 2017 SIP.

In addition, during the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, the Company issued ~~447,620~~132,826 shares of common stock with an aggregate fair value of ~~$200,794~~$80,456 to certain employees related to the Company’s ~~2017,~~ 2018 and 2019 management incentive plans.

During the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, the Company accrued ~~$120,000~~$50,000 of management and employee bonus expense. ~~The Company has typically paid a substantial portion of the bonus accrual with shares of common stock.~~

On January 8, 2021, the Company entered into a Warrant Amendment and Exercise Agreement (the “Amendment Agreement”) with holders (the “Holder”) of a common stock purchase warrant, dated April 4, 2019, previously issued by the Company to the Holder (the “Original Warrant”).

In consideration for each exercise of the Original Warrant that occurs within 45 calendar days of the date of the Amendment Agreement, in addition to the issuance of the Warrant Shares (as defined in the Original Warrant) on or prior to the Warrant Share Delivery Date (as defined in the Original Warrant), the Company has agreed to deliver to the Investor a new warrant to purchase a number of shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), equal to the number of Original Warrants that the Holder has exercised pursuant to the terms of the Original Warrant, at an exercise price of $1.525 per share, which represents the average Nasdaq Official Closing Price of the Common Stock (as reflected on Nasdaq.com) for the five trading days immediately preceding the date of the Amendment Agreement (the “New Warrants”). The Investor originally held Original Warrants exercisable for up to 2,469,136 shares of Common Stock, and, therefore, could receive up to an equivalent number of New Warrants. Under the terms and conditions of the Warrant Amendment and Exercise Agreement, the Investor could continue to exercise the Original Warrants after 45 calendar days of the date of the Amendment Agreement, but the Investor would not receive any New Warrants in consideration for the exercise of any Original Warrants exercised thereafter.

The Amendment Agreement contains customary representations, warranties and covenants by each of the Company and the Investor.

On January 29, 2021 and February 8, 2021, the Investor exercised 500,000 and 1,969,136, respectively of the Original Warrants. The New Warrants issued, are exercisable for up to the original expiration dates of the Original Warrants, which is April 4, 2024. The exercise price and number of shares issuable upon exercise of the New Warrants are subject to traditional adjustment for stock splits, combinations, recapitalization events and certain dilutive issuances. The New Warrants are required to be exercised for cash; however, if during the term of the New Warrants there is not an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”), covering the resale of the shares of Common Stock issuable upon exercise of the New Warrants, then the New Warrants may be exercised on a cashless (net exercise) basis pursuant to the formula provided in the New Warrants.

The Company intends to use the proceeds from the exercise of the Original Warrants for working capital purposes, the launch of new products and to reduce its debt outstanding.

The Company recorded a warrant modification expense of $2,881,729 for the three months ended March 31, 2021 resulting from the issuance of 2,469,136 replacement warrants with an exercise price of $1.525 for warrants that were exercised during the three months ended March 31, 2021.

As of ~~September 30, 2020,~~March 31, 2021, the Company had outstanding warrants to purchase an aggregate of ~~12,302,939~~9,378,133 shares of common stock with a weighted average exercise price and remaining life of ~~$1.87~~$1.70 and ~~3.66~~3.71 years, respectively. During the three months ended March 31, 2021, 86,072 warrants expired. At ~~September 30, 2020, all of~~March 31, 2021, the warrants ~~were exercisable and~~ had noan aggregate intrinsic ~~value.~~value of $2,328,639.

During the three months ended March 31, 2021, 3,749,000 warrants were exercised on a cashless basis and were converted into 2,073,687 shares of common stock.

On February 24, 2020, Michael J. Orlando, as shareholder representative (the “Shareholder Representative”), and the other stockholders of Fit Pay, Inc. (collectively, the “Fit Pay Shareholders”), filed a lawsuit in the United States District Court for the Southern District of New York against the Company, CrowdOut Capital, LLC, and Garmin International, Inc. (the “Complaint”). See Orlando v. Nxt-ID, Inc. No. 20-cv-1604 (S.D.N.Y.). The Complaint alleges that the Company has breached certain contractual obligations under a merger agreement, dated May 23, 2017, between Fit Pay, Inc. and the Company, regarding certain future, contingent earnout payments allegedly that could be owed to the Fit Pay Shareholders from future revenues. The Complaint seeks unspecified monetary damages from the defendants. The Company believes that these claims are without merit and ~~plans to~~is vigorously ~~defend~~defending the action. ~~The Company waived service of the summons and received an automatic extension of time to answer the Complaint.~~ On May 12, 2020, the Company filed an answer and counterclaims alleging, among other things, fraud and breach of fiduciary duty of the Shareholder Representative as well as arguing that the Shareholder Representative should be estopped from pursuing these claims. The Company has moved for summary judgment to have the lawsuit dismissed. The Company has been able to successfully stay discovery pending the court’s ruling on motions to dismiss by Garmin International, Inc. and CrowdOut Capital, LLC. ~~Since~~In March 2021, following our successful application to stay all discovery, the ~~litigation~~court granted CrowdOut’s and Garmin’s separate motions to dismiss. Orlando’s claim against the Company still remains and the Company’s motion for summary judgment is still ~~in its early stages, the Company is not yet able to evaluate the likelihood of an unfavorable outcome or estimate the amount or range of potential loss.~~pending.

In connection with the sale of Fit-Pay, Inc., Giesecke+Devrient Mobile Security America, Inc. (“GDMSAI”) has identified a disagreement with the Company over calculation of dividends with respect to GDMSAI’s Series C Non-Convertible Voting Preferred Stock (the “Series C”) of the Company. On August 13, 2020, the Company was sued by GDMSAI seeking, among other things, $440,000 of dividends that it believes are owed to it pursuant to the terms of the Series C. The Company believes that GDMSAI’s claims are not correct and plans to vigorously defend the action. The Company has moved to have the case removed from Delaware to New York, where the Company claims the forum clause requires the claims to be heard. The Company has opposed GDMSAI’s motion for summary judgment. ~~Since~~In March 2021, a Delaware Chancery court rejected our argument that the Fit Pay merger agreement requires litigation solely in New York and thereafter granted GDMSAI summary judgment on the merits, holding that relevant dividend language required a perpetually paid dividend once the $50M threshold had been achieved. The Company has filed a notice of appeal and plans to appeal the Delaware Chancery court decision. There are no assurances that our appeal will be successful and even if our appeal is ~~still~~successful that a New York court will agree with our interpretation of the manner in ~~its early stages,~~which dividends on the Series C Preferred are to be calculated. If the Company is ~~not yet able~~unsuccessful, it will be responsible for paying $440,000 of dividends plus interest. The judgment may also trigger an event of default with our senior debt facility. Although the Company is attempting to ~~evaluate~~negotiate a waiver of this provision in its credit agreement, there are no assurances that it will be successful in doing so or on terms reasonably favorable to the ~~likelihood of an unfavorable outcome or estimate the amount or range of potential loss beyond the amount stated in the action.~~ Company.

From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of our business. Other than the above, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any of our subsidiaries, threatened against or affecting our company, or any of our subsidiaries in which an adverse decision could have a material adverse effect upon our business, operating results, or financial condition.

The Company leases office space and a fulfillment center in the U.S., which are classified as operating leases expiring at various dates. The Company determines if an arrangement qualifies as a lease at the lease inception. ~~The Company adopted Topic 842 effective January 1, 2019.~~ Operating lease liabilities are recorded based on the present value of the future lease payments over the lease term, assessed as of the commencement date. The Company’s real estate leases, which are for office space and a fulfillment center, generally have a lease term between 3 and 5 years. The Company also leases a copier with a lease term of 5 years. The Company’s leases are comprised of fixed lease payments and also include executory costs such as common area maintenance, as well as property insurance and property taxes. ~~As a practical expedient under Topic 842, the~~The Company has elected to account for the lease and non-lease components as a single lease component for its real estate leases. Lease payments, which may include lease components, non-lease components and non-components, are included in the measurement of the Company’s lease liabilities to the extent that such payments are either fixed amounts or variable amounts based on a rate or index (fixed in substance) as stipulated in the lease contract. Any actual costs in excess of such amounts are expensed as incurred as variable lease cost.

The Company’s lease agreements generally do not specify an implicit borrowing rate, and as such, the Company utilizes its incremental borrowing rate by lease term, in order to calculate the present value of the future lease payments. The discount rate represents a risk-adjusted rate on a secured basis, and is the rate at which the Company would borrow funds to satisfy the scheduled lease liability payment streams commensurate with the lease term. On January 1, 2019, the discount rate used on existing leases at adoption was determined based on the remaining lease term using available data as of that date. The Company’s lease agreement for its former warehouse space located in Louisville, Kentucky expired on August 31, 2020. As a result, the Company entered into a new five-year lease agreement in June 2020 for new warehouse space also located in Louisville, Kentucky. The monthly rent which commenced in September 2020 is $6,000 per month and increases approximately 3% annually thereafter. The ROU asset value added as a result of this new lease agreement was $279,024. The Company’s ROU asset and lease liability accounts reflect the inclusion of this new lease agreement on the Company’s condensed consolidated balance sheet as of ~~September 30, 2020.~~March 31, 2021.

Certain of the Company’s lease agreements, primarily related to real estate, include options for the Company to either renew (extend) or early terminate the lease. Leases with renewal options allow the Company to extend the lease term typically between 1 and 3 years. Renewal options are reviewed at lease commencement to determine if such options are reasonably certain of being exercised, which could impact the lease term. When determining if a renewal option is reasonably certain of being exercised, the Company considers several factors, including but not limited to, significance of leasehold improvements incurred on the property, whether the asset is difficult to replace, or specific characteristics unique to the particular lease that would make it reasonably certain that the Company would exercise such option. In most cases, the Company has concluded that renewal and early termination options are not reasonably certain of being exercised by the Company (and thus not included in the Company’s ROU asset and lease liability) unless there is an economic, financial or business reason to do so.

For the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, total operating lease cost was ~~$113,257~~$26,736 and is recorded in cost of sales and selling, general and administrative expenses, dependent on the nature of the leased asset. The operating lease cost is recognized on a straight-line basis over the lease term. The following summarizes (i) the future minimum undiscounted lease payments under non-cancelable lease for the remainder of ~~2020~~2021 as well as each of the next five years and thereafter, incorporating the practical expedient to account for lease and non-lease components as a single lease component for our existing real estate leases, (ii) a reconciliation of the undiscounted lease payments to the present value of the lease liabilities recognized, and (iii) the lease-related account balances on the Company’s condensed consolidated balance sheet, as of ~~September 30, 2020:~~March 31, 2021:

Year Ended December 31,
2020 (excluding the nine months ended September 30, 2020)	$	22,546
2021		90,986
Year Ending December 31,

2021 (excluding the three months ended March 31, 2021)				$	68,439
2022		93,385			93,385
2023		89,724			89,724
2024		80,000			80,000
2025		54,400			54,400
Total future minimum lease payments	$	431,041		$	385,948
Less imputed interest		(110,264	)		(90,412	)
Total present value of future minimum lease payments	$	320,777		$	295,536

As of September 30, 2020
As of March 31, 2021

Operating lease right-of-use assets	$	320,378	$	292,797

Other accrued expenses	$	52,199	$	56,827
Other long-term liabilities	$	268,578	$	238,709
	$	320,777	$	295,536

On March 11, 2020, the ~~coronavirus that causes~~World Health Organization designated COVID-19 ~~was reported to have surfaced in China. The Company’s primary supply chain is located in China~~as a global pandemic. Sales volumes and ~~other Asian-based locations. To date,~~the related revenues for most of the Company’s ~~supply chain~~products and services were significantly impacted during the latter portion of the first quarter and throughout the balance of 2020 as a result of the healthcare industry’s focus on COVID prevention and treatment, which impacted the markets we serve, in particular the VA hospitals and clinics. Sales of the Company’s products and services have continued to be impacted as various policies were implemented by federal, state and local governments in response to the COVID-19 pandemic, the public remains wary of real or perceived opportunities for exposure to the virus. The Company believes the extent of the COVID-19 pandemic’s impact on its operating results and financial condition has ~~not experienced any significant disruptions. The global spread~~been and will continue to be driven by many factors, most of ~~this virus has caused significant business disruption around~~which are beyond the ~~world including the United States, the primary area in which~~Company’s control and ability to forecast. Although the Company ~~operates and sells its products. The business disruption is currently expected to be temporary, however there is considerable uncertainty around~~has experienced some positive trends during the ~~duration~~first four months of ~~the business disruption. Therefore,~~2021, because of these uncertainties, the Company ~~expects this matter~~cannot estimate how long or to ~~continue to negatively~~what extent the pandemic will impact ~~the Company’s financial condition, results of operations, or cash flows.~~its operations.

The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued.

On ~~November 16, 2020,~~May 3, 2021, the ~~Company and CrowdOut Capital~~Company’s wholly-owned subsidiary, LogicMark, LLC, ~~as administrative agent, entered into the first amendment~~made a $3,000,000 voluntary prepayment (the ~~“First Amendment”~~“Prepayment”) ~~to the senior secured~~on its term loan. ~~In connection with~~The Company did not incur a prepayment premium as it relates to this voluntary prepayment. After this prepayment, the ~~First Amendment, CrowdOut Capital LLC, as administrative agent, agreed to modify the financial ratios contained in the senior secured~~Company’s term loan ~~retroactively and prospectively. Based on the senior secured term loan, as amended, the Company was in compliance with such financial covenant requirements as of September 30, 2020.~~balance is $2,236,502.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations for the ~~nine and~~ three months ended ~~September 30, 2020~~March 31, 2021 should be read together with our condensed consolidated financial statements and related notes included elsewhere in this quarterly report. This discussion contains forward-looking statements and information relating to our business that reflect our current views and assumptions with respect to future events and are subject to risks and uncertainties that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These forward-looking statements speak only as of the date of this report. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, or achievements. Except as required by applicable law, including the securities laws of the United States, we expressly disclaim any obligation or undertaking to disseminate any update or revisions of any of the forward-looking statements to reflect any change in our expectations with regard thereto or to conform these statements to actual results.

We were incorporated in the State of Delaware on February 8, 2012. ~~As of December 31, 2018, we are no longer an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”).~~ We ~~are a security~~provide technology ~~company and we operate our business in one segment – hardware and software security systems and applications. We are engaged in the development of proprietary~~ products and ~~solutions that serve multiple end markets, including the security,~~services for healthcare ~~financial technology and the Internet of Things (“IoT”) markets.~~applications. We evaluate the performance of our business on, among other things, profit and loss from operations. ~~With~~We have extensive experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization, ~~and~~ sensor technologies, ~~we develop and market solutions for payment, IoT~~ and healthcare applications.

Our wholly-owned subsidiary, LogicMark, manufactures and distributes non-monitored and monitored personal emergency response systems sold through the United States Department of Veterans Affairs (the “VA”), healthcare durable medical equipment dealers and distributors and monitored security dealers and distributors.

Our former wholly-owned subsidiary, Fit Pay, Inc., had a proprietary technology platform that delivers payment, credential management, authentication and other secure services to the IoT ecosystem. The platform uses tokenization, a payment security technology that replaces cardholders’ account information with a unique digital identifier, to transact highly secure contactless payment and authentication services. On September 21, 2018, we announced that our board of directors approved a plan to separate our financial technology business from our healthcare business into an independent publicly traded company. We originally planned to distribute shares of PartX, Inc., a newly created company and wholly-owned subsidiary of the Company (“PartX”), to our stockholders through the execution of a spin-off. As a result, we reclassified our financial technology business to discontinued operations for all periods reported. Our financial technology business was comprised of our Fit Pay subsidiary and the intellectual property developed by the Company, including the Flye Smartcard and the Wocket. On April 29, 2019, a Registration Statement on Form 10 was filed by PartX with the SEC in connection with the planned spin-off of our payments, authentication and credential management business. On August 19, 2019, our subsidiary, PartX notified the SEC that it was withdrawing the Registration Statement on Form 10. With the approval of our board of directors, and upon similar terms and conditions to those set forth in that loan agreement, we entered into a non-binding letter of intent for the sale of our Fit Pay subsidiary, excluding certain assets on August 6, 2019. In connection with the letter of intent, we were advanced $500,000 of non-interest bearing working capital for Fit Pay. On September 9, 2019, we completed the sale of our Fit Pay subsidiary to Garmin International, Inc. for $3.32 million in cash.

With respect to the healthcare market, our business initiatives are driven by LogicMark, which serves a market that enables two-way communication, medical device connectivity and patient data tracking of key vitals through sensors, biometrics, and security to make home health care a reality. There are four (4) major trends driving this market: (1) an increased desire for connectivity; specifically, a greater desire for connected devices by people over 60 years of age who now represent the fastest growing demographic for social media; (2) the growth of “TeleHealth”, which is the means by which telecommunications technologies are meeting the increased need for health systems to better distribute doctor care across a wider range of health facilities, making it easier to treat and diagnose patients; (3) rising healthcare costs – as healthcare spending continues to outpace the economy, the need to reduce hospital readmissions, increase staffing efficiency and improve patient engagement remain the highest priorities; and (4) the critical shortage of labor in the home healthcare industry, creating an increased need for technology to improve communication to home healthcare agencies by their clients. Together, these trends have produced a large and growing market for us to serve. LogicMark has built a successful business on emergency communications in healthcare. We have a strong business relationship with the VA today, serving veterans who suffer from chronic conditions that often require emergency assistance. ~~This business is steady and growing, producing the highest annual revenue in its operational history in 2019.~~ Our strategic plan calls for expanding LogicMark’s business into other healthcare verticals as well as retail and enterprise channels in order to better serve the expanding demand for connected and remote healthcare solutions.

Home healthcare, is an emerging area for LogicMark. The long-term trend toward more home-based healthcare is a massive shift that is being driven by demographics (an aging population) and basic economics. People also value autonomy and privacy which are important factors in determining which solutions will suit the market. Consumers are beginning to enjoy the benefits of smart home technologies and online digital assistants.

PERS devices are used to call for help and medical care during an emergency. These devices are also used by a wide patient pool, as well as the general population, to ensure safety and security when living or traveling alone. The global medical alert systems market caters to different end-users across the healthcare industry, including individual users, hospitals and clinics, assisted living facilities and senior living facilities. The growing demand for home healthcare devices is mainly driven by an aging population, rising healthcare costs and a severe shortage of workers in the home healthcare market worldwide. It is very beneficial for seniors who have a history of falling or have been identified as having a high fall risk, older individuals who live alone and people who have mobility issues. We believe that the aging population will spur the usage of medical alert systems across the globe, as they offer safety and medical security while being affordable and accessible.

Our former wholly-owned subsidiary, Fit Pay, Inc., had a proprietary technology platform that delivered payment, credential management, authentication and other secure services to the IoT ecosystem. The platform used tokenization, a payment security technology that replaces cardholders’ account information with a unique digital identifier, to transact highly secure contactless payment and authentication services. Fit Pay connected its customers to leading payment card networks, including VISA, Mastercard, Maestro and Discover, and to credit card issuing banks globally. Fit Pay also commercialized its third-party token service provider platform with the launch of Garmin Pay, which was powered by Fit Pay’s platform. Fit Pay’s technology and tokenization service enabled the contactless payment feature that is included in smart watches manufactured by Garmin.

On September 21, 2018, we announced that our board of directors approved a plan to separate our financial technology business from our healthcare business into an independent publicly traded company. We originally planned to distribute shares representing our financial technology business into a newly created company and wholly-owned subsidiary of the Company (which we named “PartX”), to our stockholders through the execution of a spin-off. As a result, we reclassified our financial technology business to discontinued operations for all periods reported. Our financial technology business was comprised of our Fit Pay subsidiary and the intellectual property developed by the Company, including the Flye Smartcard and the Wocket. On April 29, 2019, a Registration Statement on Form 10 was filed by PartX with the SEC in connection with the planned spin-off of our payments, authentication and credential management business. On August 19, 2019, our subsidiary, PartX notified the SEC that it was withdrawing the Registration Statement on Form 10 as PartX was unable to secure sufficient investment within the time period specified in a term loan agreement to separately fund the spinoff. With the approval of our board of directors, and upon similar terms and conditions to those set forth in that loan agreement, we entered into a non-binding letter of intent for a potential sale of our Fit Pay subsidiary, excluding certain assets on August 6, 2019. In connection with the letter of intent, the purchaser advanced $500,000 of non-interest bearing working capital for Fit Pay. On September 9, 2019, we completed the sale of our Fit Pay subsidiary to Garmin International, Inc. for $3.32 million in cash.

Comparison of ~~nine and~~ three months ended ~~September 30,~~March 31, 2021 and March 31, 2020 ~~and September 30, 2019~~

Revenue. Our revenues for the ~~nine and~~ three months ended ~~September 30, 2020~~March 31, 2021 were ~~$8,866,205 and $2,639,193, respectively,~~$2,438,682, compared to ~~$13,112,952 and $4,444,431, respectively~~$3,744,029 for the ~~nine and~~ three months ended ~~September 30, 2019.~~March 31, 2020. The decrease in our revenues for the ~~nine and~~ three months ended ~~September 30, 2020~~March 31, 2021 as compared to the ~~nine and~~ three months ended ~~September 30, 2019~~March 31, 2020 is attributable to LogicMark’s decreased sales volume resulting primarily from the COVID-19 pandemic.

Cost of Revenue and Gross Profit. Our gross profit for the three months ended March 31, 2021 was $1,550,589 compared to a gross profit of $2,795,905 for the three months ended March 31, 2020. The decrease in gross profit in the three months ended March 31, 2021 as compared to the three months ended March 31, 2020 is primarily attributable to LogicMark’s decreased sales volume resulting from the COVID-19 ~~pandemic.~~pandemic and to a lesser extent higher cost of goods sold resulting from the higher product cost of the Company’s new 4G product.

~~Cost of Revenue and Gross Profit.~~ Our gross profit for the nine and three months ended September 30, 2020 was $6,488,057 and $1,878,228, respectively, compared to a gross profit of $9,906,612 and $3,337,058, respectively for the nine and three months ended September 30, 2019. The decrease in gross profit in the nine and three months ended September 30, 2020 as compared to the nine and three months ended September 30, 2019 is primarily attributable to LogicMark’s decreased sales volume resulting primarily from the COVID-19 pandemic.

Operating Expenses. Operating expenses for the ~~nine~~three months ended ~~September 30, 2020~~March 31, 2021 totaled ~~$6,078,402~~$2,333,479 and consisted of research and development expenses of ~~$757,221,~~$274,915, selling and marketing expenses of ~~$1,865,626~~$560,441 and general and administrative expenses of ~~$3,455,555.~~$1,498,123. The research and development expenses related primarily to salaries and consulting services of ~~$669,892.~~$242,583. Selling and marketing expenses consisted primarily of salaries and consulting services of ~~$396,286,~~$126,171, amortization of intangibles of ~~$569,796,~~$187,845, freight charges of ~~$412,883,~~$106,425, merchant processing fees of ~~$190,727,~~$51,501, and sales commissions of ~~$180,870.~~$55,061. General and administrative expenses consisted of salaries and consulting services of ~~$661,042, accrued management and employee incentives of $120,000, legal, audit and accounting fees of $1,430,182 and insurance of $351,429.~~

Operating expenses for the nine months ended September 30, 2019 totaled $8,108,967 and consisted of research and development expenses of $962,537, selling and marketing expenses of $2,503,594 and general and administrative expenses of $4,642,836. The research and development expenses related primarily to salaries and consulting services of $750,984. Selling and marketing expenses consisted primarily of salaries and consulting services of $528,473, amortization of intangibles of $569,796, freight charges of $489,234, merchant processing fees of $317,925, and sales commissions of $223,782. General and administrative expenses consisted of salaries and consulting services of $1,363,703, accrued management and employee incentives of $234,785 and legal, audit and accounting fees of $647,298. Also included in general and administrative expenses is $266,780 in non-cash stock compensation to consultants and board members.

Operating expenses for the three months ended September 30, 2020 totaled $2,404,653 and consisted of research and development expenses of $257,832, selling and marketing expenses of $577,085 and general and administrative expenses of $1,569,736. The research and development expenses related primarily to salaries and consulting services of $233,547. Selling and marketing expenses consisted primarily of salaries and consulting services of $106,770, amortization of intangibles of $192,019, freight charges of $141,522, merchant processing fees of $55,385, and sales commissions of $56,604. General and administrative expenses consisted of salaries and consulting services of $206,085, accrued management and employee incentives of $40,000, legal, audit and accounting fees of $864,793 and insurance of $125,514.

Operating expenses for the three months ended September 30, 2019 totaled $2,610,515 and consisted of research and development expenses of $354,257, selling and marketing expenses of $760,011 and general and administrative expenses of $1,496,247. The research and development expenses related primarily to salaries and consulting services of $231,520. Selling and marketing expenses consisted primarily of salaries and consulting services of $167,785, amortization of intangibles of $192,018, freight charges of $164,352, merchant processing fees of $106,659 and sales commissions of $74,861. General and administrative expenses consisted of salaries and consulting services of $420,293,$169,154, accrued management and employee incentives of $50,000 and legal, audit and accounting fees of ~~$224,572.~~$252,821. Also included in general and administrative expenses is ~~$95,024~~$648,000 in non-cash stock compensation expense to ~~consultants~~management and board members.

Operating ~~Profit.~~ ~~The operating profit (loss)~~expenses for the ~~nine and~~ three months ended ~~September 30,~~March 31, 2020 totaled $1,756,499 and consisted of research and development expenses of $186,612, selling and marketing expenses of $725,681 and general and administrative expenses of $844,206. The research and development expenses related primarily to salaries and consulting services of $149,445. Selling and marketing expenses consisted primarily of salaries and consulting services of $167,817, amortization of intangibles of $187,845, freight charges of $170,127, merchant processing fees of $81,343, and sales commissions of $67,856. General and administrative expenses consisted of salaries and consulting services of $237,393, accrued management and employee incentives of $40,000 and legal, audit and accounting fees of $156,517.

Operating (Loss) Profit. The operating loss for the three months ended March 31, 2021 was ~~$409,655 and $(526,425), respectively,~~$782,890 compared with operating profit of ~~$1,797,645 and $726,543, respectively~~$1,039,406 for the ~~nine and~~ three months ended ~~September 30, 2019.~~March 31, 2020. The decrease in operating profit for the ~~nine and~~ three months ended ~~September 30, 2020~~March 31, 2021 as compared to the ~~nine and~~ three months ended ~~September 30, 2019~~March 31, 2020 is primarily attributable to ~~the~~ lower gross profit ~~discussed in this section above and the legal fees incurred as a result of the two lawsuits we are currently involved in,~~resulting from LogicMark’s lower sales volume which was ~~offset in part by lower~~primarily attributable to the COVID-19 pandemic and higher product cost as discussed above. In addition, operating expenses incurred in the ~~nine and~~ three months ended ~~September 30, 2020~~March 31, 2021 as compared to the ~~nine and~~ three months ended ~~September 30, 2019.~~March 31, 2020 were higher primarily due to the stock compensation expense recorded in the three months ended March 31, 2021.

Net ~~Loss.~~(Loss) Income. The net loss for the nine months ended September 30, 2020 was $1,307,906 compared to a net loss of $2,871,864 for the nine months ended September 30, 2019. The net loss for the nine months ended September 30, 2020 was primarily attributable to the operating profit discussed above of $409,655 which was offset by interest expense incurred of $1,717,561. The net loss for the nine months ended September 30, 2019 was $2,871,864 and was primarily attributable to the operating profit discussed above of $1,797,645 and a favorable change in fair value of contingent consideration of $85,111, all of which was offset by interest expense incurred of $2,410,741 and a loss on the extinguishment of debt of $2,343,879.

The net loss for the three months ended ~~September 30, 2020~~March 31, 2021 was ~~$1,078,341~~$4,222,157 compared to a net ~~loss~~income of ~~$406,730~~$438,064 for the three months ended ~~September 30, 2019.~~March 31, 2020. The net loss for the three months ended ~~September 30, 2020~~March 31, 2021 was primarily attributable to the operating loss discussed above of ~~$526,425 and~~$782,890, interest expense incurred of ~~$551,916.~~$861,248, and warrant modification expense of $2,881,729, all of which was partially offset by the gain of $303,710 resulting from the forgiveness of the PPP loan and accrued interest. The net ~~loss~~income for the three months ended ~~September 30, 2019~~March 31, 2020 was ~~$406,730~~$438,064 and was primarily attributable to ~~the~~ operating profit ~~discussed above~~ of ~~$726,543 all of which was~~$1,039,406 offset by interest expense incurred of ~~$1,133,273.~~$601,342.

We generated an operating ~~income~~loss of ~~$409,655~~$782,890 and ~~incurred~~ a net loss of ~~$1,307,906~~$4,222,157 for the ~~nine~~three months ended ~~September 30, 2020.~~March 31, 2021. As of ~~September 30, 2020,~~March 31, 2021, we had cash and stockholders’ equity of ~~$2,092,532~~$8,515,824 and ~~$7,451,852,~~$18,490,578, respectively. At ~~September 30, 2020,~~March 31, 2021, we had a working capital ~~deficiency~~ of ~~$2,137,343.~~$3,919,847.

Given our cash position at ~~September 30, 2020~~March 31, 2021 and our projected cash flow from operations, we believe that we will have sufficient capital to sustain operations for a period of one year following the date of this filing. We may also raise funds through equity or debt offerings to increase our working capital and to accelerate the execution of our long-term strategic plan to develop and commercialize our core products and to fulfill our product development commitments.

On November 16, 2020, the Company and CrowdOut Capital LLC, as administrative agent, entered into the first amendment (the “First Amendment”) to the senior secured term loan. In connection with the First Amendment, CrowdOut Capital LLC, as administrative agent, agreed to modify the financial ratios contained in the senior secured term loan retroactively and prospectively. Based on the senior secured term loan, as amended, the Company was in compliance with such financial covenant requirements as of September 30, 2020.

Cash Generated by Operating Activities. Our primary ongoing uses of operating cash relate to payments to subcontractors and vendors for product, research and development, salaries and related expenses and professional fees. Our vendors and subcontractors generally provide us with normal trade payment terms. During the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, net cash ~~provided by~~used in operating activities totaled ~~$15,643,~~$1,002,766, which was comprised of a net loss of ~~$1,307,906,~~$4,222,157, positive non-cash adjustments to reconcile net loss to net cash used in operating activities of ~~$1,235,432,~~$3,302,130, and ~~net positive~~ changes in operating assets and liabilities of ~~$88,117,~~negative $82,739, as compared to net cash provided by operating activities of ~~$1,480,123~~$517,260 for the ~~nine~~three months ended ~~September 30, 2019,~~March 31, 2020, which was comprised of a net ~~loss~~income of ~~$2,871,864,~~$438,064, positive non-cash adjustments to reconcile net ~~loss~~income to net cash used in operating activities of ~~$4,116,928,~~$421,732, and ~~net positive~~ changes in operating assets and liabilities of ~~$235,059.~~negative $342,536.

Cash Used in Investing Activities. During the ~~nine~~three months ended ~~September 30,~~March 31, 2021 and 2020, we did not have any net cash used in investing activities. During the nine months ended September 30, 2019 net cash provided by investing activities totaled $2,750,314 and was primarily related to the net proceeds received from the sale of our discontinued operations of $2,955,170 offset in part by earn out payments to the Fit Pay Sellers totaling $181,065 and the purchase of equipment of $23,791.

Cash Provided by Financing Activities. During the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, net cash provided by financing activities totaled ~~$489,639~~$5,131,174 and was primarily related to the proceeds received ~~in connection with~~from the exercising of warrants into common stock of $6,670,494 and from the issuance of ~~common~~Series E preferred stock ~~par value $0.0001 per share (“Common Stock”),~~ of ~~$1,864,528 and loan proceeds of $346,390 received under the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act~~$4,000,003, all of which was partially offset by ~~our~~ term loan repayments ~~of $1,696,875~~totaling $5,515,625 and fees paid in connection with equity offerings ~~totaling $24,404.~~of $23,698. During the ~~nine~~three months ended ~~September 30, 2019,~~March 31, 2020, net cash used in financing activities totaled ~~$1,477,929~~$665,625 and was ~~primarily~~ related to ~~the pay down of $16,000,000 related to the~~our term loan facility with Sagard Holdings Manager, LP, pay downs in both the short and long-term debt totaling $638,881, scheduled term loan repayments of $687,500 and fees paid in connection with equity offerings totaling $47,671. We also prepaid $1,988,498 of the term loan facility with a portion of the net proceeds received from the sale of our discontinued operations. These financing disbursements were funded in part with $1,299,042 in net proceeds received from the sale of our Common Stock from our January 2019 At-the-Market Offering, $1,915,000 in net proceeds received from the sale of shares of our Common Stock in connection with a registered direct public offering and $14,670,579 in net proceeds received from the refinancing with CrowdOut Capital, which closed on May 3, 2019.repayments.

~~The~~On March 11, 2020, the World Health Organization designated COVID-19 ~~pandemic represents~~as a ~~fluid situation that presents a wide range of potential impacts of varying durations~~global pandemic. Sales volumes and the related revenues for ~~different global geographies, including locations where we have offices, employees, customers, vendors and other suppliers and business partners.~~

~~Like~~ most ~~US-based businesses, the COVID-19 pandemic and efforts to mitigate the same began to have impacts on our business in March 2020. By that time, much~~ of our products and services were significantly impacted during the latter portion of the first ~~fiscal~~ quarter ~~was completed. During~~and throughout the ~~quarters ended June 30,~~balance of 2020 ~~and September 30, 2020, we have observed decreases in demand from certain customers, primarily our VA hospitals.~~

~~Given the fact our products are sold through a variety of distribution channels, including through hospitals, we expect our sales will experience more volatility~~ as a result of the ~~changing~~healthcare industry’s focus on COVID prevention and ~~less predictable operational needs~~treatment, which impacted the markets we serve, in particular the VA hospital and clinics. Sales of ~~many customers~~our products and services have continued to be impacted as ~~a result~~various policies were implemented by federal, state and local governments in response to the COVID-19 pandemic, the public remains wary of real or perceived opportunities for exposure to the virus. We believe the extent of the COVID-19 ~~pandemic. We~~pandemic’s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are ~~aware that many companies, including many of~~beyond our ~~suppliers~~control and ~~customers, are reporting or predicting negative impacts from COVID-19 on future operating results.~~ability to forecast. Although we ~~observed significant declines in demand for our products from certain customers~~have experienced some positive trends during the ~~three~~first four months ~~ended June 30, 2020,~~of 2021, because of these uncertainties, we ~~believe that it remains too early for us~~cannot estimate how long or to ~~know~~what extent the ~~exact~~pandemic will impact ~~COVID-19 will have on the long-term demand for~~ our ~~products. We also cannot be certain how demand may shift over time as the impacts of the COVID-19 pandemic may go through several phases of varying severity and duration.~~

In light of broader macro-economic risks and already known impacts on certain industries that use our products and services, during 2020 we ~~have taken and are taking~~took targeted steps to lower our operating expenses because of the COVID-19 pandemic. We continue to monitor the impacts of COVID-19 on our operations closely and this situation could change based on a significant number of factors that are not entirely within our control and are discussed in this and other sections of this ~~quarterly~~ report on Form 10-Q. We do not expect there to be material changes to our assets on our balance sheet or our ability to timely account for those assets. Further, in connection with the preparation of this quarterly report on Form 10-Q and the interim financial statements contained herein, we reviewed the potential impacts of the COVID-19 pandemic on goodwill and intangible assets and have determined there to be no material impact at this time. We have also reviewed the potential impacts on future risks to the business as it relates to collections, returns and other business-related items.

To date, travel restrictions and border closures have not materially impacted our ability to obtain inventory or manufacture or deliver products or services to ~~customers. However, if such restrictions become more severe,~~customers; however, they could negatively impact those activities in a way that would harm our business over the long term. Travel restrictions impacting people can restrain our ability to assist our customers and distributors as well as impacthave impacted our ability to develop new ~~distribution channels, but at present we do not expect these restrictions on personal travel to be material to our business operations or financial results.~~markets and visit certain facilities, particularly VA hospital. We have taken steps to restrain and monitor our operating expenses and ~~therefore~~continue to monitor the trends in our business and broader economy to ensure that we ~~do not expect~~properly track any ~~such impacts~~material changes to ~~materially change~~ the relationship between costs and revenues.

Like most companies, we have taken a range of actions with respect to how we operate to assure we comply with government restrictions and guidelines as well as best practices to protect the health and well-being of our employees and our ability to continue operating our business effectively. To date, we have been able to operate our business effectively using these measures and to maintain internal controls as documented and posted. We also have not experienced challenges in maintaining business continuity and do not expect to incur material expenditures to do so. However, the impacts of COVID-19 and efforts to mitigate the same have remained unpredictable and it remains possible that challenges may arise in the future.

~~The actions we have taken so far during the pandemic include, but are not limited to:~~

On each of May 6 and May 8, 2020, we and LogicMark, LLC, our wholly-owned subsidiary, received loans (the “Loans”) from Bank of America, NA in the aggregate amount of $346,390.00, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act, which was enacted on March 27, 2020. Under the terms of the PPP, PPP loans and accrued interest are forgivable after twenty-four weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees or reduces salaries during the eight-week period. As of June 30, 2020, we have used the entirety of the loan proceeds for purposes consistent with the PPP and have not taken any actions that we believe will reduce the amount eligible for forgiveness. As such, the Company believes that the entire amount of the PPP loans will be eligible for forgiveness. However, to the extent any portion of the loan is determined to be ineligible for forgiveness, such unforgiven portion of the loan is payable over 2-5 years at an interest rate of 1%, with a deferral of payments for the first six months.

We currently believe revenue for the three months ended December 31, 2020 will decline significantly year over year due to the conditions noted. In April 2020, we implemented a COVID-19 mitigation plan designed to further reduce our operating expenses. Actions taken to date include work hour and salary reductions for senior management. These cost reductions are in addition to the significant restructuring actions we initiated in the fourth quarter of 2019. Based on our current cash position, our projected cash flow from operations and our cost reduction and cost containment efforts to date, we believe that we will have sufficient capital to sustain operations for a period of one year following the date of this filing. If business interruptions resulting from COVID-19 were to be prolonged or expanded in scope, our business, financial condition, results of operations and cash flows would be negatively impacted. We will continue to actively monitor this situation and will implement actions necessary to maintain business continuity.

Our future financial performance depends, in large part, on conditions in the markets that we serve and on conditions in the U.S. During the quarter ended September 30, 2020, the impact of the COVID-19 pandemic significantly affected our results of operations as we experienced meaningful reductions in customer demand for our products and services. During the third quarter, the Company continued to identify and assess risks and modify operating plans following guidance from national, state and local governmental and health authorities. During the third quarter, although we continued to experience minimal supply chain disruption, customer demand was noticeably weaker. In addition, during the third quarter, we took several proactive measures to protect the Company’s balance sheet and strengthen its liquidity position, including: making additional cost reductions through executive wage rollbacks, discretionary spending reductions, corporate travel suspension, and service provider and other expense reductions as well as leveraging government work programs and tax deferrals and extensions to the extent they do not incur interest rate fees or penalties.

The COVID-19 pandemic and its effects on the economic environment remain extremely fluid and it is difficult to predict with certainty what unforeseen circumstances may develop as we progress through the remainder of the year. As a result, we will continue to proceed cautiously by managing our cost structure and cash flows. In addition, we are rethinking our strategic plans to best position our company to adapt to these changing conditions and to continue to serve our customers and community.

The Company’s priorities during the COVID-19 pandemic are protecting the health and safety of our employees and rethinking and reevaluating our operational and strategic plans to overcome the current challenges. In the quarter ended September 30, 2020, the COVID-19 pandemic had a material net impact on our consolidated operating results. In the future, the pandemic may cause continued or prolonged reduced demand for our products or services if, for example, the pandemic results in a recessionary economic environment to the markets that we serve; however since the products and services that we offer are essential to the daily lives of our current and future customers, we believe that over the long term, there will continue to be strong demand for our products and services as we rethink our distribution paradigm in the post-COVID-19 environment.

Our ability to operate without significant negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees, with particular measures in place for those working in our customer facilities. For the nine months ended September 30, 2020, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain as well as impact the purchasing decisions by some of our larger customers.

Through September 30, 2020, the pandemic has not materially impacted the Company’s liquidity position as of such date, however, during the six-month period ended September 30, 2020, we failed to generate operating cash flow as we had in the first quarter of 2020 prior to the COVID-19 pandemic. We currently expect to maintain access to the capital markets should the effects of the pandemic on our operations continue. We have not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.

~~For additional information on risk factors related to the pandemic or other risks that could impact our results, please refer to “Risk Factors” in Part II, Item 1A of this Form 10-Q.~~

The Company conducts an annual impairment review of goodwill and indefinite-lived intangible assets each year, unless events occur which trigger the need for an interim impairment review. During the first quarter of 2020, the Company considered the economic impact of the COVID-19 pandemic to be a triggering event for an interim impairment review. Because we were in the early stages of the pandemic, we elected not to undertake a formal review of our assets for impairment purposes.

During the third quarter of 2020, the Company, as part of its annual evaluation of goodwill, considered the economic impact of the COVID-19 pandemic on the Company’s operations and determined there was no triggering event, particularly inasmuch as the Company’s sales began to recover during the second half of the third quarter of 2020. The Company continues to monitor the impact of the pandemic on its business and anticipates continuing to review guidance issued by the Securities and Exchange Commission (the “SEC”) as well as governing audit bodies to guide its future reviews and posture.

We believe that our business has not been affected to a significant degree by inflationary trends during the past three years. However, inflation is still a factor in the worldwide economy and may increase the cost of purchasing products from our contract manufacturers in Asia, as well as the cost of certain raw materials, component parts and labor used in the production of our products. It also may increase our operating expenses, manufacturing overhead expenses and the cost to acquire or replace fixed assets. We have generally been able to maintain or improve our profit margins through productivity and efficiency improvements, cost reduction programs and to a lesser extent, price increases, and we expect to be able to do the same during the remainder of fiscal year ~~2020.~~2021. As such, we do not believe that inflation will have a significant impact on our business during the remainder of fiscal year ~~2020.~~2021.

We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not have any undisclosed borrowings or debt, and we have not entered into any synthetic leases. We are, therefore, not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

See Note 3 to our condensed consolidated financial statements for the ~~nine~~three months ended ~~September 30, 2020,~~March 31, 2021, included elsewhere in this document.

We are not required to provide the information required by this Item since we are a smaller reporting company, as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we are required to perform an evaluation of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Exchange Act, as of ~~September 30, 2020.~~March 31, 2021. Management has not completed such evaluation but has concluded, based on the material weaknesses in our internal controls over financial reporting described below, that our disclosure controls and procedures were not effective as of ~~September 30, 2020~~March 31, 2021 to provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

As reported in our annual report on Form 10-K for the period ended December 31, 2020, during the closing procedures associated with its 2020 audit, management identified an employee theft event involving a non-material amount of money for the fiscal year ended December 31, 2020. Management determined that the incident was due to a material weakness in its controls and procedures, specifically as a result of the lack of segregation of duties due to the limited number of employees performing certain administrative functions. In order to remediate the material weakness and further strengthen the controls, management initiated or enhanced certain receivables handling procedures by strictly controlling access to incoming mail and physical checks received by the Company. During the first quarter of 2021, we hired a forensic auditor who evaluated our transactions and determined that the incident was isolated. The Company was made whole during the quarter ended March 31, 2021.

As of ~~September 30, 2020,~~March 31, 2021, our management concluded that certain previously disclosed material weaknesses in our internal controls over financial reporting continue to exist. Specifically, we have difficulty in accounting for complex accounting transactions due to an insufficient number of accounting personnel with experience in that area and limited segregation of duties within our accounting and financial reporting functions. Management has recently hired an assistant controller with significant experience to help address this situation. Additional time is required to expand our staff, fully document our systems, implement control procedures and test their operating effectiveness before we can conclude that we have remediated our material weaknesses.

There were no changes in the Company’s internal control over financial reporting that occurred during the three months ended ~~September 30, 2020~~March 31, 2021 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Our management, including our Chief Executive Officer and Chief Financial Officer, dodoes not expect that our disclosure controls and procedures will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include, but are not limited to, the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

On February 24, 2020, Michael J. Orlando, as shareholder representative (the “Shareholder Representative”), and the other stockholders of Fit Pay, Inc. (collectively, the “Fit Pay Shareholders”), filed a lawsuit in the United States District Court for the Southern District of New York against the Company, CrowdOut Capital, LLC, and Garmin International, Inc. (the “Complaint”). See Orlando v. Nxt-ID, Inc. No. 20-cv-1604 (S.D.N.Y.). The Complaint alleges that the Company has breached certain contractual obligations under a merger agreement, dated May 23, 2017, between Fit Pay, Inc. and the Company, regarding certain future, contingent earnout payments allegedly that could be owed to the Fit Pay Shareholders from future revenues. The Complaint seeks unspecified monetary damages from the defendants. ~~We believe~~The Company believes that these claims are without merit and ~~plan~~plans to vigorously defend the action. ~~We waived service of the summons and received an automatic extension of time to answer the Complaint.~~ On May 12, 2020, wethe Company filed an answer and counterclaims alleging, among other things, fraud and breach of fiduciary duty of the Shareholder Representative as well as arguing that the Shareholder Representative should be estopped from pursuing these claims. The Company has moved for summary judgment to have the lawsuit dismissed. The Company has been able to successfully stay discovery pending the court’s ruling on motions to dismiss by Garmin International, Inc. and CrowdOut Capital, LLC. ~~Since~~In March 2021, following our successful application to stay all discovery, the ~~litigation~~court granted CrowdOut’s and Garmin’s separate motions to dismiss. Orlando’s claim against the Company still remains and the Company’s motion for summary judgment is still ~~in its early stages, we are not yet able to evaluate the likelihood of an unfavorable outcome or estimate the amount or range of potential loss.~~pending.

In connection with the sale of Fit-Pay, Inc., Giesecke+Devrient Mobile Security America, Inc. (“GDMSAI”) has identified a disagreement with usthe Company over calculation of dividends with respect to GDMSAI’s Series C Non-Convertible Voting Preferred Stock (the “Series C”) of the Company. On August 13, 2020, the Company was sued by GDMSAI seeking, among other things, $440,000 of dividends that it believes are owed to it pursuant to the terms of the Series C. ~~We believe~~The Company believes that GDMSAI’s claims are not correct ~~and plan to~~is vigorously ~~defend~~defending the action. The Company ~~has~~ moved to have the case removed from Delaware to New York, where the Company claims the forum clause requires the claims to be heard. The Company has opposed GDMSAI’s motion for summary judgment. ~~Since~~In March 2021, a Delaware Chancery court rejected our argument that the Fit Pay merger agreement requires litigation solely in New York and thereafter granted GDMSAI summary judgment on the merits, holding that relevant dividend language required a perpetually paid dividend once the $50M threshold had been achieved. The Company has filed a notice of appeal and plans to appeal the Delaware Chancery court’s decision. There are no assurances that our appeal will be successful and even if our appeal is ~~still~~successful that a New York court will agree with our interpretation of the manner in ~~its early stages,~~which dividends on the Series C Preferred are to be calculated. If we are ~~not yet able~~unsuccessful, we will be responsible for paying $440,000 of dividends plus interest. The judgment may also trigger an event of default with our senior debt facility. Although we are attempting to ~~evaluate~~negotiate a waiver of this provision in our credit agreement, there are no assurances that we will be successful in doing so or on terms reasonably favorable to the ~~likelihood of an unfavorable outcome or estimate the amount or range of potential loss beyond the amount stated in the action.~~ Company.

From time to time, wethe Company may be involved in various claims and legal actions arising in the ordinary course of our business. Other than the above, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of ~~our company~~the Company or any of our subsidiaries, threatened against or affecting our company, or any of our subsidiaries in which an adverse decision could have a material adverse effect upon our business, operating results, or financial condition.

The risk factors set forth below contain material changes to the risk factors previously disclosed and included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the SEC on March 30, 2020 (the “2019 10-K”), and our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2020, filed with the SEC on August 14, 2020 (the “Q2 10-Q”). When evaluating our business and our prospects, you should consider the risks and uncertainties described under Item 1A of Part I of the 2019 10-K and Item 1A of Part II of the Q2 10-Q, as updated in this Item 1A. You should also refer to the other information set forth in this Quarterly Report on Form 10-Q and in the 2019 10-K and the Q2 10-Q, including our financial statements and the related notes. These risks and uncertainties are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently consider immaterial may also impair our business operations. If any of the risks or uncertainties actually occur, our business and financial results could be harmed. In that case, the market price of our Common Stock could decline.

~~Our supply chains in China subject us to risks and uncertainties relating to the laws and regulations of China and the changes in relations between the United States and China.~~

Under its current leadership, the government of China has been pursuing economic reform policies, including by encouraging foreign trade and investment. However, there is no assurance that the Chinese government will continue to pursue such policies, that such policies will be successfully implemented, that such policies will not be significantly altered, or that such policies will be beneficial to our supply chains in China. China’s system of laws can be unpredictable, especially with respect to foreign investment and foreign trade. The United States government has called for substantial changes to foreign trade policy with China and has raised (as well as has proposed to further raise in the future), tariffs on several Chinese goods. China has retaliated with increased tariffs on United States goods. Moreover, China’s legislature has recently adopted a national security law to substantially change the way Hong Kong has been governed since the territory was handed over by the United Kingdom to China in 1997. This law increases the power of the central government in Beijing over Hong Kong, limits the civil liberties of residents of Hong Kong and could restrict the ability of businesses in Hong Kong to continue to conduct business or to continue to conduct business as previously conducted. The U.S. State Department has indicated that the United States no longer considers Hong Kong to have significant autonomy from China and President Trump signed an executive order and the Hong Kong Autonomy Act to remove Hong Kong’s preferential trade status. The United States may impose the same tariffs and other trade restrictions on exports from Hong Kong that it places on goods from mainland China. Any further changes in United States trade policy could trigger retaliatory actions by affected countries, including China, resulting in trade wars. Any changes in United States and China relations may have a material adverse effect on our supply chains in China which could materially harm our business and financial condition.

~~Our business, financial condition and results of operations may be adversely affected by the recent coronavirus outbreak or other similar epidemics or adverse public health developments~~

The COVID-19 Pandemic has caused many governments to implement quarantines and significant restrictions on travel, and to advise that people remain at home where possible and avoid crowds. This has led to many businesses shutting down or limiting operations as well as greater uncertainty in financial markets. Any economic downturns or adverse impacts resulting from COVID-19 or other similar epidemics or adverse public health developments may increase the likelihood of our distributors and/or the VA significantly reducing orders for our products or being unable to pay us in accordance with the terms of already fulfilled orders. To the extent we experience, delays or disruptions, such as difficulty obtaining components and temporary suspension of operations, our existing inventory levels may not be sufficient, and our business, financial condition and results of operations could be materially and adversely affected, in the event that the slowdown or suspension carries on for a long period of time. As a result of the current or future epidemics, we may also be impacted by shutdowns, employee impacts from illness and other community response measures meant to prevent spread of the virus, all of which could negatively impact our business, financial condition and results of operations. Further, if we are regularly unable to meet our obligations to deliver our products to distributors and/or the VA, they may decide to terminate or reduce their distribution arrangements with us and our business could be adversely affected. The extent to which the COVID-19 impacts our results will depend on future developments, which are highly uncertain and will include emerging information concerning the severity of the COVID-19 and the actions taken by governments and private businesses to attempt to contain the virus.

We have been notified by Nasdaq of our failure to comply with certain continued listing requirements and if we are unable to regain compliance with all applicable continued listing requirements and standards of Nasdaq, our Common Stock will be delisted from Nasdaq.

Our Common Stock is currently listed on Nasdaq. In order to maintain that listing, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders’ equity, minimum share price, and certain corporate governance requirements. There can be no assurances that we will be able to comply with the applicable listing standards.

In the event that our Common Stock is delisted from Nasdaq and is not eligible for quotation on another market or exchange, trading of our Common Stock could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of, or obtain accurate price quotations for, our Common Stock, and it would likely be more difficult to obtain coverage by securities analysts and the news media, which could cause the price of our Common Stock to decline further. Also, it may be difficult for us to raise additional capital ifsmaller reporting company, we are not ~~listed on a national exchange.~~

~~On May 24, 2019, we received written notice from~~required to provide the staff (the “Staff”) of the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price for our Common Stock, had closed below $1.00 per share for the previous 30 consecutive trading days (the “Minimum Bid Price Requirement”). Further, as previously disclosed on its Current Report on Form 8-K, filed with the SEC on November 21, 2019, we received notice from Nasdaq indicating that, while the Company had not regained compliance with the Minimum Bid Price Requirement, the Staff had determined that we were eligible for an additional 180-day period, or until May 18, 2020, to regain compliance.

On April 17, 2020, we received notice from Nasdaq that the 180-day grace period to regain compliance with the Minimum Bid Price Requirement under applicable Nasdaq rules was extended due to the global market impact causedinformation required by COVID-19. More specifically, Nasdaq has stated that the compliance periods for any company previously notified about non-compliance will be suspended effective April 16, 2020, through June 30, 2020. On July 1, 2020, companies would receive the balance of any pending compliance period exception to come back into compliance with the applicable Minimum Bid Price Requirement. As a result of this extension, the Company had until August 3, 2020 to regain compliance with the Minimum Bid Price Requirement. Since the Company did not satisfy the Minimum Bid Price Requirement by August 3, 2020, the Company received written notification (the “Letter”) from Nasdaq that the Company’s shares of Common Stock would be delisted, unless the Company requested a hearing to appeal Nasdaq’s determination. On August 6, 2020, the Company requested a hearing before the Nasdaq Hearings Panel (the “Hearings Panel”) to appeal the Letter and, on August 7, 2020, Nasdaq notified the Company that a hearing was scheduled for September 10, 2020. The Company provided the Hearings Panel with a plan to regain compliance with the Minimum Bid Price Requirement while requesting additional time to effect compliance with the Minimum Bid Price Requirement by securing authorization for a reverse stock split of the Company’s Common Stock (the “Common Stock Reverse Stock Split”), as further explained in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the SEC on August 17, 2020. On September 16, 2020, the Hearings Panel granted the Company’s request for additional time, until October 31, 2020, to complete the Common Stock Reverse Stock Split and demonstrate compliance with the Minimum Bid Price Requirement, which deadline to regain compliance with the Minimum Bid Price Requirement was subsequently extended until November 30, 2020 in response to the Company’s request for such extension.Item.

Although we received authorization at the 2019 annual meeting for a reverse stock split, the authorization expired on May 18, 2020, during the midst of the COVID-19 pandemic and we believed that it was not in our stockholders’ best interests to implement such reverse during the period of extreme volatility and uncertainty, particularly inasmuch as Nasdaq had provided an extension to comply. The Company’s 2020 Annual Meeting of Stockholders, which has been adjourned to Tuesday, November 17, 2020 (the “Annual Meeting”), requests authorization from the Company’s stockholders to approve the Common Stock Reverse Stock Split. There can be no assurances that we will be able to obtain such stockholder approval at the Annual Meeting. If we fail to obtain stockholder approval, our Common Stock will be delisted.

In the event that we are delisted from Nasdaq, our Common Stock may lose liquidity, increase volatility, and lose market maker support. If we are unable to maintain compliance with these Nasdaq requirements, including the Minimum Bid Price Requirement, our Common Stock will be delisted from Nasdaq, which may negatively impact the value of our securities.

On July 14, 2020, the Company closed a registered direct offering (the “July Registered Direct Offering”) of (i) an aggregate of 3,778,513 shares (the “Shares”) of Common Stock; (ii) pre-funded warrants to purchase up to an aggregate of 734,965 shares of Common Stock (the “Pre-Funded Warrant Shares”) at an exercise price of $0.01 per share, subject to customary adjustments thereunder (the “Pre-Funded Warrants”); (iii) warrants, with a term of five (5) years exercisable immediately upon issuance, to purchase an aggregate of up to 1,579,718 shares of Common Stock (the “Registered Warrant Shares”) at an exercise price of $0.50 per share, subject to customary adjustments thereunder (the “Registered Warrants”); and (iv) warrants, with a term of five and one-half (5.5) years first exercisable six (6) months after issuance, to purchase an aggregate of up to 3,750,000 shares of Common Stock (the “Unregistered Warrant Shares”) at an exercise price of $0.65 per share, subject to customary adjustments thereunder (the “Unregistered Warrants”), for gross proceeds of $1,864,528, before deducting any offering expenses.None.

The Company entered into a securities purchase agreement on July 10, 2020 with two (2) accredited investors (“Investors”) providing for the issuance of the Shares, the Pre-Funded Warrants, the Registered Warrants and the Unregistered Warrants (the “Purchase Agreement”). The Shares, the Pre-Funded Warrants, the Pre-Funded Warrant Shares, the Registered Warrants and the Registered Warrant Shares were registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to a prospectus supplement to the Company’s currently effective registration statement on Form S-3 (File No. 333-228624), which was initially filed with the SEC on November 30, 2018 and was declared effective on December 12, 2018 (the “Shelf Registration Statement”). The Company filed the prospectus supplement to the Shelf Registration Statement with the SEC on July 13, 2020. Pursuant to the Purchase Agreement, the Unregistered Warrants and the Unregistered Warrant Shares were issued to the Investors in a concurrent private placement transaction pursuant to an exemption from the registration requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.

With respect to the availability of an exemption from registration, relating to the sale of the Unregistered Warrants and the Unregistered Warrant Shares in the July Registered Direct Offering, we made these determinations based on the representations of each investor which included, in pertinent part, that each such investor was either (a) an “accredited investor” within the meaning of Rule 501 of Regulation D or (b) a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act and upon such further representations from each investor that (i) such investor acquired the securities for his, her or its own account for investment and not for the account of any other person and not with a view to or for distribution, assignment or resale in connection with any distribution within the meaning of the Securities Act, (ii) such investor agreed not to sell or otherwise transfer the purchased securities unless they are registered under the Securities Act and any applicable state securities laws, or an exemption or exemptions from such registration are available, (iii) such investor had knowledge and experience in financial and business matters such that he, she or it was capable of evaluating the merits and risks of an investment in us, (iv) such investor had access to all of our documents, records, and books pertaining to the investment and was provided the opportunity to ask questions and receive answers regarding the terms and conditions of the offering and to obtain any additional information which we possessed or were able to acquire without unreasonable effort and expense, and (v) such investor had no need for the liquidity in its investment in us and could afford the complete loss of such investment. In addition, there was no general solicitation or advertising for securities issued in reliance upon these exemptions.

There have been no material changes to the procedures by which security holders may recommend nominees to our Board of Directors.

~~In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.~~

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.~~

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

Delaware		46-0678374
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

Title of each class		Trading Symbol(s)		Name of exchange on which registered
Common Stock, par value $0.0001 per share		NXTD		Nasdaq Capital Market

		Page

PART I.	FINANCIAL INFORMATION	1

Item 1.	Financial Statements (Unaudited):	1

	Condensed Consolidated Balance Sheets at ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020	1
	~~Condensed Consolidated Statements of Operations for the Nine Months Ended September 30, 2020 and 2019~~	2
	Condensed Consolidated Statements of Operations for the Three Months Ended ~~September 30, 2020~~March 31, 2021 and ~~2019~~2020	32

	Condensed Consolidated Statements of Changes in Equity for the ~~Nine and~~ Three Months Ended ~~September 30, 2020~~March 31, 2021 and 2020	~~4-5~~3

	~~Condensed Consolidated Statements of Changes in Equity for the Nine and Three Months Ended September 30, 2019~~	~~6-7~~
	Condensed Consolidated Statements of Cash Flows for the ~~Nine~~Three Months Ended ~~September 30, 2020~~March 31, 2021 and ~~2019~~2020	85

	Notes to Condensed Consolidated Financial Statements	96

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1716

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2419

Item 4.	Controls and Procedures	2419

PART II.	OTHER INFORMATION	2520

Item 1.	Legal Proceedings	2520

Item 1A.	Risk Factors	2520

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2720

Item 3.	Defaults upon Senior Securities	2720

Item 4.	Mine Safety Disclosures	2720

Item 5.	Other Information	2720

Item 6.	Exhibits	2721

Signatures	28	22

	Preferred Stock				Common Stock				Additional Paid-in			Accumulated
	Shares		Amount		Shares		Amount		Capital			Deficit			Total
Balance – July 1, 2020		-	$	-		30,496,474	$	3,050	$	68,722,019		$	(62,033,656	)	$	6,691,413

Issuance of stock options for services						-		-		40,000			-			40,000

Issuance of common stock and warrants for cash						4,513,478		451		1,864,077			-			1,864,528

Fees incurred in connection with equity offerings						-		-		(40,748	)		-			(40,748	)

Net loss						-		-		-			(1,078,341	)		(1,078,341	)

Preferred stock dividends										(25,000	)					(25,000	)

Balance – September 30, 2020		-	$	-		35,009,952	$	3,501	$	70,560,348		$	(63,111,997	)	$	7,451,852

	Preferred Stock				Common Stock				Additional Paid-in			Accumulated
	Shares		Amount		Shares		Amount		Capital			Deficit			Total
Balance – January 1, 2019		-	$	-		25,228,072	$	2,523	$	64,748,871		$	(50,014,636	)	$	14,736,758

Issuance of common stock for services						770,827		77		534,413			-			534,490

Issuance of common stock under the at-the-market program for cash, net of fees						1,113,827		111		1,298,931			-			1,299,042

Issuance of common stock and warrants for cash, net of fees						2,469,136		247		1,914,753			-			1,915,000

Shares issued in connection with the management incentive plan for 2017 and 2018						289,216		29		216,238			-			216,267

Fees incurred in connection with equity offerings						-		-		(127,514	)		-			(127,514	)

Net loss						-		-		-			(12,292,901	)		(12,292,901	)

Preferred stock dividends										(125,000	)					(125,000	)

Balance – September 30, 2019		-	$	-		29,871,078	$	2,987	$	68,460,692		$	(62,307,537	)	$	6,156,142

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

	For the Nine Months Ended September 30,			For the Three Months Ended September 30,
	2019			2019
Net sales	$	625,771		$	171,709
Cost of sales		194,856			72,980
Gross profit		430,915			98,729
Operating expenses		3,859,222			1,339,621
Interest expense		3,963			838
Loss from discontinued operations	$	(3,432,270	)	$	(1,241,730	)

As of ~~September 30, 2020~~March 31, 2021

Weighted Average Remaining Lease Term	~~4.67~~4.03 years
Weighted Average Discount Rate	~~12.80~~12.86	%

Exhibit Number		Description
10.1*		~~First Amendment to Senior Secured Credit Agreement, dated as of November 16, 2020~~
31.1*		Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**32.1		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**32.2		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
~~101.INS~~		~~XBRL Instance Document~~
~~101.SCH~~		~~XBRL Schema Document~~
~~101.CAL~~		~~XBRL Calculation Linkbase Document~~
~~101.DEF~~		~~XBRL Definition Linkbase Document~~
~~101.LAB~~		~~XBRL Label Linkbase Document~~
~~101.PRE~~		~~XBRL Presentation Linkbase Document~~

	~~Nxt-ID, Inc.~~

~~Date: November 16, 2020~~	~~By:~~	~~/s/ Vincent S. Miceli~~
		~~Vincent S. Miceli~~
		~~Chief Executive Officer and~~ ~~Chief Financial Officer~~ ~~(Duly Authorized Officer and~~ ~~Principal Executive Officer and~~ ~~Principal Financial Officer)~~

~~Exhibit~~ ~~Number~~		~~Description~~
10.1*		~~First Amendment to Senior Secured Credit Agreement, dated as of November 16, 2020~~
31.1*		~~Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002~~
31.2*		~~Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002~~
32.1**		~~Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002~~
32.2**		~~Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002~~
101.INS		XBRL Instance Document
101.SCH		XBRL Schema Document
101.CAL		XBRL Calculation Linkbase Document
101.DEF		XBRL Definition Linkbase Document
101.LAB		XBRL Label Linkbase Document
101.PRE		XBRL Presentation Linkbase Document

	Nxt-ID, Inc.

Date: May 17, 2021	By:	/s/ Vincent S. Miceli
		Vincent S. Miceli
		Chief Executive Officer and Chief Financial Officer (Duly Authorized Officer and Principal Executive Officer and Principal Financial Officer)